"Questions and Answers: The NIH Trial of EDTA Chelation Therapy for Coronary Artery Disease"
Documentation should record the exact GLP-1RA, formulation, dose, route, titration schedule, indication, prescriber, baseline and follow-up weight, BMI, HbA1c, fasting glucose, lipid profile, and Psoriasis Area and Severity Index (PASI)/Body Surface Area (BSA), Dermatology Life Quality Index (DLQI), pruritus, and joint symptoms
SGLT2i also provided protection against the worsening of CKD class and the doubling of serum creatinine (ITT population) or new-onset CKD (on-treatment population)
Damman K, Valente MAE, Voors AA, OConnor CM, van Veldhuisen DJ, Hillege HL
Use the contents within 3 months of first broaching and discard any unused portion